When should anti-vascular endothelial growth factor treatment be stopped in age-related macular degeneration?
Gaudric
Alain
A
Cohen
Salomon Y
SY
D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D006801:Humans; D008268:Macular Degeneration / Q000188:drug therapy*; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*; D014792:Visual Acuity / Q000502:physiology
D020533:Angiogenesis Inhibitors; D042461:Vascular Endothelial Growth Factor A